source
- VectorY Therapeutics raises $83.5M Series A to develop brain-targeted antibody gene therapyVectorY Therapeutics announced it has closed a Series A financing round, adding €74.5 million ($83.5 million) to its capital. The funds will be used to advance its lead gene-therapy candidate VTx-…
- U.S. faces possible loss of measles elimination status as WHO panel convenesA WHO regional committee will meet for four days to decide if the United States still meets criteria for measles elimination. Current indicators suggest the country may no longer qualify, raising…